1. Megari K. Quality of Life in Chronic Disease Patients. Health psychology research. 2013;1(3):e27.
2. Tsokos GC. Systemic lupus erythematosus. The New England journal of medicine. 2011;365(22):2110-21.
3. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical care. 1992;30(6):473-83.
4. Alarcon GS, McGwin G, Jr., Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis and rheumatism. 2004;51(3):465-74.
5. Doria A, Rinaldi S, Ermani M, Salaffi F, Iaccarino L, Ghirardello A, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. 2004;43(12):1580-6.
6. Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, et al. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clinical rheumatology. 2016;35(3):617-22.
7. Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL. Quality of life in patients with systemic lupuserythematosus (SLE) compared with related controls within a unique African American population. Lupus. 2012;21(5):563-9.
8. Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scandinavian journal of rheumatology. 2009;38(2):121-7.
9. Chaigne B, Chizzolini C, Perneger T, Trendelenburg M, Huynh-Do U, Dayer E, et al. Impact of disease activity on health-related quality of life in systemiclupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS). BMC immunology. 2017;18(1):17.
10. Shen B, Feng G, Tang W, Huang X, Yan H, He Y, et al. The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis. Clinical and experimental rheumatology. 2014;32(1):101-7.
11. Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality oflife in systemic lupus erythematosus. Rheumatology. 2004;43(12):1536-40.
12. Freire EA, Bruscato A, Leite DR, Sousa TT, Ciconelli RM. Translation into Brazilian Portuguese, cultural adaptation and validatation of the systemic lupus erythematosus quality of life questionnaire (SLEQOL). Acta reumatologica portuguesa. 2010;35(3):334-9.
13. Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology. 2005;44(10):1267-76.
14. Kasitanon N, Wangkaew S, Puntana S, Sukitawut W, Leong KP, Tan Tock Seng Hospital Lupus Study G, et al. The reliability, validity and responsiveness of the Thai version of Systemic Lupus Erythematosus Quality of Life (SLEQOL-TH) instrument. Lupus. 2013;22(3):289-96.
15. Rinaldi S, Doria A, Salaffi F, Ermani M, Iaccarino L, Ghirardello A, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology. 2004;43(12):1574-9.
16. Jolly M, Pickard SA, Mikolaitis RA, Rodby RA, Sequeira W, Block JA. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. The Journal of rheumatology. 2010, 37:1828–33.